465 related articles for article (PubMed ID: 30689031)
1. Does whole-body Patlak
Fahrni G; Karakatsanis NA; Di Domenicantonio G; Garibotto V; Zaidi H
Eur Radiol; 2019 Sep; 29(9):4812-4821. PubMed ID: 30689031
[TBL] [Abstract][Full Text] [Related]
2. Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction: evaluation of 103 dynamic whole-body
Dias AH; Pedersen MF; Danielsen H; Munk OL; Gormsen LC
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):837-850. PubMed ID: 32894338
[TBL] [Abstract][Full Text] [Related]
3. Direct inference of Patlak parametric images in whole-body PET/CT imaging using convolutional neural networks.
Zaker N; Haddad K; Faghihi R; Arabi H; Zaidi H
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4048-4063. PubMed ID: 35716176
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Analysis of Heterogeneous [
Zhuang M; Karakatsanis NA; Dierckx RAJO; Zaidi H
Mol Imaging Biol; 2019 Apr; 21(2):317-327. PubMed ID: 29956119
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Lesion Detectability in Dynamic Whole-Body PET Imaging Using Compartmental and Patlak Parametric Mapping.
Zaker N; Kotasidis F; Garibotto V; Zaidi H
Clin Nucl Med; 2020 May; 45(5):e221-e231. PubMed ID: 32108696
[TBL] [Abstract][Full Text] [Related]
6. First results on kinetic modelling and parametric imaging of dynamic
Sari H; Mingels C; Alberts I; Hu J; Buesser D; Shah V; Schepers R; Caluori P; Panin V; Conti M; Afshar-Oromieh A; Shi K; Eriksson L; Rominger A; Cumming P
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1997-2009. PubMed ID: 34981164
[TBL] [Abstract][Full Text] [Related]
7. Impact of Tissue Classification in MRI-Guided Attenuation Correction on Whole-Body Patlak PET/MRI.
Zhuang M; Karakatsanis NA; Dierckx RAJO; Zaidi H
Mol Imaging Biol; 2019 Dec; 21(6):1147-1156. PubMed ID: 30838550
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PET.
Karakatsanis NA; Zhou Y; Lodge MA; Casey ME; Wahl RL; Zaidi H; Rahmim A
Phys Med Biol; 2015 Nov; 60(22):8643-73. PubMed ID: 26509251
[TBL] [Abstract][Full Text] [Related]
10. Dual-time point
Parghane RV; Basu S
Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
[TBL] [Abstract][Full Text] [Related]
11. Accurate total-body K
Chen Z; Cheng Z; Duan Y; Zhang Q; Zhang N; Gu F; Wang Y; Zhou Y; Wang H; Liang D; Zheng H; Hu Z
Med Phys; 2023 Apr; 50(4):2121-2134. PubMed ID: 35950784
[TBL] [Abstract][Full Text] [Related]
12. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
Kramer GM; Frings V; Hoetjes N; Hoekstra OS; Smit EF; de Langen AJ; Boellaard R
J Nucl Med; 2016 Sep; 57(9):1343-9. PubMed ID: 27103020
[TBL] [Abstract][Full Text] [Related]
13. Comparison of parametric imaging and SUV imaging with [
Chen R; Ng YL; Yang X; Zhu Y; Li L; Zhao H; Zhou Y; Huang G; Liu J
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):568-580. PubMed ID: 37792025
[TBL] [Abstract][Full Text] [Related]
14. The clinical value of texture analysis of dual-time-point
Nakajo M; Jinguji M; Aoki M; Tani A; Sato M; Yoshiura T
Eur Radiol; 2020 Mar; 30(3):1759-1769. PubMed ID: 31728684
[TBL] [Abstract][Full Text] [Related]
15. Test-Retest Repeatability of Patlak Slopes versus Standardized Uptake Values for Hypermetabolic Lesions and Normal Organs in an Oncologic PET/CT Population.
Ince S; Laforest R; Ashrafinia S; Smith AM; Wahl RL; Fraum TJ
Mol Imaging Biol; 2024 Apr; 26(2):284-293. PubMed ID: 38466523
[TBL] [Abstract][Full Text] [Related]
16. Parametric net influx rate imaging of
Yin H; Liu G; Mao W; Lv J; Yu H; Cheng D; Cai L; Shi H
Ann Nucl Med; 2024 Apr; ():. PubMed ID: 38573411
[TBL] [Abstract][Full Text] [Related]
17. Defining optimal tracer activities in pediatric oncologic whole-body
Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF; Schäfer JF
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2283-2289. PubMed ID: 27565153
[TBL] [Abstract][Full Text] [Related]
18. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Static and Dynamic
Braune A; Hofheinz F; Bluth T; Kiss T; Wittenstein J; Scharffenberg M; Kotzerke J; Gama de Abreu M
J Nucl Med; 2019 Nov; 60(11):1629-1634. PubMed ID: 31053684
[TBL] [Abstract][Full Text] [Related]
20. Can Dynamic Whole-Body FDG PET Imaging Differentiate between Malignant and Inflammatory Lesions?
Skawran S; Messerli M; Kotasidis F; Trinckauf J; Weyermann C; Kudura K; Ferraro DA; Pitteloud J; Treyer V; Maurer A; Huellner MW; Burger IA
Life (Basel); 2022 Aug; 12(9):. PubMed ID: 36143386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
